$APOG
APOGEE ENTERPRISES, INC. Stock $apog

$apog Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000000684524000222 Filed on July 09, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$342.4M	$331.5M	$361.7M
YoY Change	-3.18%	-8.35%	1.42%
Cost Of Revenue	$245.1M	$232.7M	$268.7M
YoY Change	-5.1%	-13.42%	-0.85%
Gross Profit	$97.32M	$98.86M	$92.99M
YoY Change	2.04%	6.31%	8.61%
Gross Profit Margin	28.42%	29.82%	25.71%
Selling, General & Admin	$55.36M	$57.47M	$59.22M
YoY Change	0.98%	-2.95%	13.01%
% of Gross Profit	56.88%	58.14%	63.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.688M	$9.976M	$10.28M
YoY Change	-6.85%	-2.98%	-5.23%
% of Gross Profit	9.95%	10.09%	11.06%
Operating Expenses	$55.36M	$57.47M	$59.22M
YoY Change	0.98%	-2.95%	13.01%
Operating Profit	$41.97M	$41.38M	$33.77M
YoY Change	3.48%	22.55%	1.66%
Interest Expense	$1.140M	-$450.0K	$2.036M
YoY Change	-48.88%	-122.1%	68.82%
% of Operating Profit	2.72%	-1.09%	6.03%
Other Income/Expense, Net	$290.0K	$143.0K	-$288.0K
YoY Change	-94.08%	-149.65%	-78.02%
Pretax Income	$41.12M	$41.07M	$31.44M
YoY Change	-4.88%	30.63%	2.42%
Income Tax	$10.55M	$10.06M	$7.867M
% Of Pretax Income	25.66%	24.5%	25.02%
Net Earnings	$30.57M	$31.01M	$23.58M
YoY Change	-8.28%	31.54%	3.72%
Net Earnings / Revenue	8.93%	9.35%	6.52%
Basic Earnings Per Share	$1.40	$1.42	$1.08
Diluted Earnings Per Share	$1.40	$1.41	$1.05
COMMON SHARES
Basic Shares Outstanding	21.93M shares	22.13M shares	22.27M shares
Diluted Shares Outstanding	21.88M shares	22.06M shares	22.39M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.02M	$30.36M	$24.64M
YoY Change	177.3%	23.22%	62.27%
Cash & Equivalents	$51.02M	$30.36M	$24.64M
Short-Term Investments
Other Short-Term Assets	$36.74M	$34.42M	$32.62M
YoY Change	26.54%	5.5%	68.75%
Inventory	$79.59M	$80.50M	$80.58M
Prepaid Expenses
Receivables	$226.4M	$227.2M	$255.9M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$393.8M	$372.5M	$393.7M
YoY Change	4.64%	-5.39%	6.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$240.6M	$281.0M	$246.3M
YoY Change	-2.0%	14.08%	3.76%
Goodwill	$129.1M	$129.0M	$129.1M
YoY Change	-0.02%	-0.01%	-0.92%
Intangibles	$64.55M	$64.98M	$66.31M
YoY Change	-1.16%	-2.0%	-7.16%
Long-Term Investments
YoY Change
Other Assets	$47.13M	$41.44M	$45.56M
YoY Change	-8.01%	-9.04%	-11.86%
Total Long-Term Assets	$523.3M	$516.5M	$527.5M
YoY Change	-1.68%	-2.08%	-1.55%
TOTAL ASSETS
Total Short-Term Assets	$393.8M	$372.5M	$393.7M
Total Long-Term Assets	$523.3M	$516.5M	$527.5M
Total Assets	$917.1M	$889.0M	$921.2M
YoY Change	0.94%	-3.5%	1.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$86.04M	$82.84M	$77.64M
YoY Change	9.85%	6.7%	-12.68%
Accrued Expenses	$53.56M	$40.99M	$77.96M
YoY Change	15.68%	-47.42%	11.86%
Deferred Revenue	$41.66M	$36.38M	$36.28M
YoY Change	28.18%	0.26%	457.77%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$238.8M	$227.1M	$233.2M
YoY Change	6.49%	-2.6%	12.6%
LONG-TERM LIABILITIES
Long-Term Debt	$62.00M	$77.00M	$170.7M
YoY Change	-57.44%	-54.88%	-34.61%
Other Long-Term Liabilities	$44.44M	$104.9M	$43.07M
YoY Change	7.34%	143.58%	-18.64%
Total Long-Term Liabilities	$106.4M	$181.9M	$213.7M
YoY Change	-43.1%	-14.89%	-31.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$238.8M	$227.1M	$233.2M
Total Long-Term Liabilities	$106.4M	$181.9M	$213.7M
Total Liabilities	$345.3M	$409.0M	$446.9M
YoY Change	-16.06%	-8.48%	-14.22%
SHAREHOLDERS EQUITY
Retained Earnings	$373.5M	$348.7M	$286.3M
YoY Change	21.16%	21.78%	37.51%
Common Stock	$7.315M	$7.312M	$7.406M
YoY Change	-0.57%	-1.27%	0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$506.4M	$480.0M	$410.2M
YoY Change
Total Liabilities & Shareholders Equity	$917.1M	$889.0M	$921.2M
YoY Change	0.94%	-3.5%	1.57%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	$30.57M	$31.01M	$23.58M
YoY Change	-8.28%	31.54%	3.72%
Depreciation, Depletion And Amortization	$9.688M	$9.976M	$10.28M
YoY Change	-6.85%	-2.98%	-5.23%
Cash From Operating Activities	$58.68M	$5.453M	$21.29M
YoY Change	42.08%	-74.38%	-169.88%
INVESTING ACTIVITIES
Capital Expenditures	$8.433M	$7.229M	$7.398M
YoY Change	10.96%	-2.28%	44.35%
Acquisitions
YoY Change
Other Investing Activities	$312.0K	-$100.0K	$466.0K
YoY Change	-152.0%	-121.46%	-566.0%
Cash From Investing Activities	-$8.121M	-$7.329M	-$6.932M
YoY Change	-0.96%	5.73%	639.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-29.71M	-4.926M	-$11.26M
YoY Change	-23.44%	-56.26%	-163.91%
NET CHANGE
Cash From Operating Activities	58.68M	5.453M	$21.29M
Cash From Investing Activities	-8.121M	-7.329M	-$6.932M
Cash From Financing Activities	-29.71M	-4.926M	-$11.26M
Net Change In Cash	20.85M	-6.802M	$3.092M
YoY Change	-465.81%	-319.99%	-122.44%
FREE CASH FLOW
Cash From Operating Activities	$58.68M	$5.453M	$21.29M
Capital Expenditures	$8.433M	$7.229M	$7.398M
Free Cash Flow	$50.25M	-$1.776M	$13.89M
YoY Change	49.1%	-112.79%	-139.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16605000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	29920000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	31011000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	23576000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21936674	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21936674	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22089265	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22089265	shares
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	232661000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	268727000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	98855000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	92986000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	57474000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	59219000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	41381000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	33767000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	450000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2036000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	143000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-288000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	41074000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31443000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10063000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7867000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	31011000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	23576000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.42
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.41
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21823000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21883000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22061000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22386000	shares
CY2024Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-1000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	33000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-6000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	121000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	364000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-121000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1196000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-397000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-669000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	435000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	521000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	159000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	31532000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23735000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	31011000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	23576000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9976000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10282000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2704000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2178000	usd
CY2024Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3466000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-165000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	27000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2895000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2714000	usd
CY2024Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	925000	usd
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	432000	usd
CY2024Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	9845000	usd
CY2023Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	13476000	usd
CY2024Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11337000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2068000	usd
CY2024Q2	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-5511000	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-14368000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1871000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8390000	usd
CY2024Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-24850000	usd
CY2023Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-13312000	usd
CY2024Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1648000	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	8158000	usd
CY2024Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3007000	usd
CY2023Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3101000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	6535000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	7590000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	6480000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	6608000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5453000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	21287000	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7229000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7398000	usd
CY2024Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	40000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	66000	usd
CY2024Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	740000	usd
CY2023Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2024Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	600000	usd
CY2023Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	400000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7329000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6932000	usd
CY2024Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	30000000	usd
CY2023Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	105852000	usd
CY2024Q2	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	15000000	usd
CY2023Q2	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	105000000	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	15061000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5193000	usd
CY2024Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
CY2023Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5245000	usd
CY2024Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-4865000	usd
CY2023Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1677000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4926000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11263000	usd
CY2024Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-51000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6853000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3169000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37216000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21473000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30363000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24642000	usd
CY2024Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	472000	usd
CY2023Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2115000	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	5409000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	471025000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	31011000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	521000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2704000	usd
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	15061000	usd
CY2024Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	4836000	usd
CY2024Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	5409000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	479955000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	396408000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	23576000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	159000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	56000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2178000	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	5193000	usd
CY2023Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	1733000	usd
CY2023Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	5245000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	410206000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	331516000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	361713000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	185986000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	176940000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2716000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3383000	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	183270000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	173557000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3383000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-659000	usd
CY2024Q2	apog	Accounts Receivable Allowance For Credit Loss Foreign Currency Effects AccountsReceivableAllowanceForCreditLossForeignCurrencyEffects	-8000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2716000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	26530000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	22745000	usd
CY2024Q2	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	3298000	usd
CY2023Q2	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	427000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	608606000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P2Y
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	352707000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P2Y
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	109831000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1071144000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	33970000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	31363000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12291000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	25586000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	80495000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	69240000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	3625000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	3608000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	7830000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	7418000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	11455000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	11026000	usd
CY2024Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	23874000	usd
CY2024Q2	apog	Long Term Investments Municipal And Corporate Bonds LongTermInvestmentsMunicipalAndCorporateBonds	11026000	usd
CY2024Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	26529000	usd
CY2024Q1	apog	Long Term Investments Municipal And Corporate Bonds LongTermInvestmentsMunicipalAndCorporateBonds	10905000	usd
CY2024Q2	apog	Maximum Number Of Acquisition Holidays MaximumNumberOfAcquisitionHolidays	2	acquisitionholiday
CY2024Q2	apog	Number Of Quarters Separating Acquisition Holidays NumberOfQuartersSeparatingAcquisitionHolidays	2	quarter
CY2024Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	15000000	usd
CY2024Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1174000	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	2510000	usd
CY2024Q2	apog	Interest Expense Income Derivatives InterestExpenseIncomeDerivatives	-236000	usd
CY2023Q2	apog	Interest Expense Income Derivatives InterestExpenseIncomeDerivatives	-267000	usd
CY2024Q2	us-gaap	Interest Expense Other InterestExpenseOther	21000	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	28000	usd
CY2024Q2	us-gaap	Interest Income Other InterestIncomeOther	509000	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	235000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	450000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	2036000	usd
CY2024Q2	us-gaap	Interest Paid InterestPaid	1100000	usd
CY2023Q2	us-gaap	Interest Paid InterestPaid	2400000	usd
CY2024Q2	us-gaap	Guarantees Fair Value Disclosure GuaranteesFairValueDisclosure	1300000000	usd
CY2024Q2	apog	Companies Backlog Related To Sales CompaniesBacklogRelatedToSales	434700000	usd
CY2024Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	21362000	usd
CY2024Q2	us-gaap	Extended Product Warranty Accrual Warranties Issued ExtendedProductWarrantyAccrualWarrantiesIssued	2399000	usd
CY2024Q2	us-gaap	Extended Product Warranty Accrual Payments ExtendedProductWarrantyAccrualPayments	3529000	usd
CY2024Q2	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	20232000	usd
CY2024Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	15000000	usd
CY2024Q2	us-gaap	Purchase Obligation PurchaseObligation	17900000	usd
CY2024Q2	apog	Number Of New Markets Tax Credit Agreements NumberOfNewMarketsTaxCreditAgreements	2	arrangement
CY2024Q2	apog	Gross Proceeds From New Markets Tax Credit Transaction GrossProceedsFromNewMarketsTaxCreditTransaction	9250000	usd
CY2024Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	2635000	usd
CY2024Q2	apog	New Markets Tax Credit Transaction Benefit Net NewMarketsTaxCreditTransactionBenefitNet	6615000	usd
CY2022Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	20000000	usd
CY2024Q1	us-gaap	Supplier Finance Program Obligation SupplierFinanceProgramObligation	6527000	usd
CY2023Q1	us-gaap	Supplier Finance Program Obligation SupplierFinanceProgramObligation	0	usd
CY2024Q2	us-gaap	Supplier Finance Program Obligation Increase SupplierFinanceProgramObligationIncrease	10342000	usd
CY2024	us-gaap	Supplier Finance Program Obligation Increase SupplierFinanceProgramObligationIncrease	33133000	usd
CY2024Q2	us-gaap	Supplier Finance Program Obligation Decrease Settlement SupplierFinanceProgramObligationDecreaseSettlement	10666000	usd
CY2024	us-gaap	Supplier Finance Program Obligation Decrease Settlement SupplierFinanceProgramObligationDecreaseSettlement	26606000	usd
CY2024Q2	us-gaap	Supplier Finance Program Obligation SupplierFinanceProgramObligation	6203000	usd
CY2024Q1	us-gaap	Supplier Finance Program Obligation SupplierFinanceProgramObligation	6527000	usd
CY2024Q2	us-gaap	Dividends Common Stock DividendsCommonStock	5400000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2023Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5200000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.24
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2700000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2200000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	10600000	usd
CY2024Q2	apog	Income Tax Expense As Percentage Of Earnings Before Income Taxes Percent IncomeTaxExpenseAsPercentageOfEarningsBeforeIncomeTaxesPercent	0.245
CY2023Q2	apog	Income Tax Expense As Percentage Of Earnings Before Income Taxes Percent IncomeTaxExpenseAsPercentageOfEarningsBeforeIncomeTaxesPercent	0.250
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5600000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5100000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21823000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21883000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	238000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	503000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22061000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22386000	shares
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	87000	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	229000	shares
CY2024Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	331516000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	361713000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	41381000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	33767000	usd
CY2024Q2	us-gaap	Restructuring Costs RestructuringCosts	1122000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	4937000	usd
CY2024Q2	us-gaap	Restructuring Charges RestructuringCharges	895000	usd
CY2024Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	2451000	usd
CY2024Q2	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	320000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	3701000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000006845-24-000222-index-headers.html	Edgar Link	pending
0000006845-24-000222-index.html	Edgar Link	pending
0000006845-24-000222.txt	Edgar Link	pending
0000006845-24-000222-xbrl.zip	Edgar Link	pending
apog-20240601.htm	Edgar Link	pending
apog-20240601.xsd	Edgar Link	pending
apog-ex311_20240601.htm	Edgar Link	pending
apog-ex312_20240601.htm	Edgar Link	pending
apog-ex321_20240601.htm	Edgar Link	pending
apog-ex322_20240601.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
apog-20240601_def.xml	Edgar Link	unprocessable
apog-20240601_lab.xml	Edgar Link	unprocessable
apog-20240601_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
apog-20240601_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
apog-20240601_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APOG
APOGEE ENTERPRISES, INC. Stock $apog

2024 Q3 Form 10-Q Financial Statement

#000000684524000222 Filed on July 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APOG APOGEE ENTERPRISES, INC. Stock $apog

2024 Q3 Form 10-Q Financial Statement

#000000684524000222 Filed on July 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APOG
APOGEE ENTERPRISES, INC. Stock $apog